Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681213 · ClinicalTrials.gov registry record · Phase 4
Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT00681213 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 150 participants.
The verdict
NCT00681213, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/Neoral®/Pred in cadaveric and non-HLA identical LRD kidney transplants.
Interventions
- DRUG Tacrolimus/Sirolimus
- DRUG Tacrolimus/MMF
- DRUG Neoral/Sirolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2000-05 |
| Est. Completion | 2002-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00681213
The ClinicalTrials.gov registry entry for NCT00681213 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tacrolimus/Sirolimus is the first listed.
NCT00681213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00681213 about?
NCT00681213 is a clinical study titled "Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation". Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/Neoral®/Pred in cadaveric and non-HLA identical LRD kidney transplants.
What is the current status of trial NCT00681213?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2000-05. Estimated completion is 2002-12.
What interventions are being tested in trial NCT00681213?
The interventions under investigation include: Tacrolimus/Sirolimus (DRUG), Tacrolimus/MMF (DRUG), Neoral/Sirolimus (DRUG).
Who is sponsoring clinical trial NCT00681213?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.